controversy about whether long-acting beta-agonists (salmeterol, etc) should be stopped once asthma is controlled
November 2012
You'll hear new controversy about whether long-acting beta-agonists (salmeterol, etc) should be stopped once asthma is controlled.
Many patients end up on a combo corticosteroid and long-acting beta-agonist inhaler (Advair, etc) when an inhaled steroid alone is not enough for persistent asthma.
But these combo inhalers have a black box warning to stop them as soon as possible once asthma is controlled due to safety concerns.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote